317 related articles for article (PubMed ID: 34399805)
21. Potential impact of (68)Ga-DOTATOC PET/CT on stereotactic radiotherapy planning of meningiomas.
Nyuyki F; Plotkin M; Graf R; Michel R; Steffen I; Denecke T; Geworski L; Fahdt D; Brenner W; Wurm R
Eur J Nucl Med Mol Imaging; 2010 Feb; 37(2):310-8. PubMed ID: 19763565
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of hitherto unknown brain meningioma detected on
Parghane RV; Talole S; Basu S
World J Nucl Med; 2019; 18(2):160-170. PubMed ID: 31040748
[TBL] [Abstract][Full Text] [Related]
23. The usefulness of [
Wang P; Liu S; Li X; Liu X; Li S; Wu Z; Cheng X
Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):218-225. PubMed ID: 37682301
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the SSTR2-targeted Radiopharmaceutical 177Lu-DOTATATE and SSTR2-specific 68Ga-DOTATATE PET as Imaging Biomarker in Patients with Intracranial Meningioma.
Kurz SC; Zan E; Cordova C; Troxel AB; Barbaro M; Silverman JS; Snuderl M; Zagzag D; Kondziolka D; Golfinos JG; Chi AS; Sulman EP
Clin Cancer Res; 2024 Feb; 30(4):680-686. PubMed ID: 38048045
[TBL] [Abstract][Full Text] [Related]
25. Impact of 68Ga-DOTATOC PET/MRI on robotic radiosurgery treatment planning in meningioma patients: first experiences in a single institution.
Acker G; Kluge A; Lukas M; Conti A; Pasemann D; Meinert F; Anh Nguyen PT; Jelgersma C; Loebel F; Budach V; Vajkoczy P; Furth C; Baur ADJ; Senger C
Neurosurg Focus; 2019 Jun; 46(6):E9. PubMed ID: 31153151
[TBL] [Abstract][Full Text] [Related]
26. [
Mahase SS; Roth O'Brien DA; No D; Roytman M; Skafida ME; Lin E; Karakatsanis NA; Osborne JR; Brandmaier A; Pannullo SC; Ramakrishna R; Stieg PE; Knisely JPS; Ivanidze J
Neurooncol Adv; 2021; 3(1):vdab012. PubMed ID: 33738446
[TBL] [Abstract][Full Text] [Related]
27. Dose-painting intensity-modulated proton therapy for intermediate- and high-risk meningioma.
Madani I; Lomax AJ; Albertini F; Trnková P; Weber DC
Radiat Oncol; 2015 Mar; 10():72. PubMed ID: 25890217
[TBL] [Abstract][Full Text] [Related]
28. Retrospective analysis of recurrence patterns and clinical outcome of grade II meningiomas following postoperative radiotherapy.
Hoffmann E; Clasen K; Frey B; Ehlers J; Behling F; Skardelly M; Bender B; Schittenhelm J; Reimold M; Tabatabai G; Zips D; Eckert F; Paulsen F
Radiat Oncol; 2021 Jun; 16(1):116. PubMed ID: 34172069
[TBL] [Abstract][Full Text] [Related]
29. Detection of Metastatic Meningioma to the Liver Using 68Ga-DOTA-Octreotate PET/CT.
Villanueva-Meyer JE; Magill ST; Lee JC; Umetsu SE; Flavell RR
Clin Nucl Med; 2018 Sep; 43(9):e338-e340. PubMed ID: 29939957
[TBL] [Abstract][Full Text] [Related]
30. Evaluating diagnostic accuracy and determining optimal diagnostic thresholds of different approaches to [
Kim SH; Roytman M; Madera G; Magge RS; Liechty B; Ramakrishna R; Pannullo SC; Schwartz TH; Karakatsanis NA; Osborne JR; Lin E; Knisely JPS; Ivanidze J
Sci Rep; 2022 Jun; 12(1):9256. PubMed ID: 35661809
[TBL] [Abstract][Full Text] [Related]
31. 68 Ga-FAPI04 Versus 68 Ga-DOTATATE PET/CT in a Patient With Multiple Meningioma.
Denizmen D; Isik EG; Buyukkaya F; Kuyumcu S
Clin Nucl Med; 2023 May; 48(5):e244-e245. PubMed ID: 36881633
[TBL] [Abstract][Full Text] [Related]
32. Simpson Grade Revisited - Intraoperative Estimation of the Extent of Resection in Meningiomas Versus Postoperative Somatostatin Receptor Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging.
Ueberschaer M; Vettermann FJ; Forbrig R; Unterrainer M; Siller S; Biczok AM; Thorsteinsdottir J; Cyran CC; Bartenstein P; Tonn JC; Albert NL; Schichor C
Neurosurgery; 2020 Dec; 88(1):140-146. PubMed ID: 32827256
[TBL] [Abstract][Full Text] [Related]
33. Postoperative [
Teske N; Biczok A; Quach S; Dekorsy FJ; Forbrig R; Bodensohn R; Niyazi M; Tonn JC; Albert NL; Schichor C; Ueberschaer M
Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):206-217. PubMed ID: 37642702
[TBL] [Abstract][Full Text] [Related]
34. Should
Babazadeh NT; Schlund DJ; Cornelius T; Singh JS; Tierney JF; Chen M; Keutgen XM
World J Surg; 2020 Feb; 44(2):604-611. PubMed ID: 31576440
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of somatostatin receptor expressing tumor volume calculated from
Toriihara A; Baratto L; Nobashi T; Park S; Hatami N; Davidzon G; Kunz PL; Iagaru A
Eur J Nucl Med Mol Imaging; 2019 Oct; 46(11):2244-2251. PubMed ID: 31350603
[TBL] [Abstract][Full Text] [Related]
36. Somatostatin receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to 68Ga-DOTATATE/-TOC uptake.
Seystahl K; Stoecklein V; Schüller U; Rushing E; Nicolas G; Schäfer N; Ilhan H; Pangalu A; Weller M; Tonn JC; Sommerauer M; Albert NL
Neuro Oncol; 2016 Nov; 18(11):1538-1547. PubMed ID: 27106404
[TBL] [Abstract][Full Text] [Related]
37. 68 Ga-DOTATATE PET to Characterize Lesions in the Neuroaxis.
Hartmann K; Gillman JA; Lazor JW; Ware JB; Weeks JK; Nasrallah IM; Farwell MD; Pantel AR
Clin Nucl Med; 2024 Jan; 49(1):9-15. PubMed ID: 38048554
[TBL] [Abstract][Full Text] [Related]
38. Complementary Molecular and Metabolic Characterization of Meningiomas With DOTATATE and FDG-PET: Advancing Treatment Planning and Prognostication.
Dressen MS; Muthukrishnan A; Tragon TR; Lieberman FS; Mountz JM
Clin Nucl Med; 2019 Jan; 44(1):e26-e27. PubMed ID: 30371576
[TBL] [Abstract][Full Text] [Related]
39. DOTATATE PET/MR Imaging Differentiates Secondary-Progressive from de Novo World Health Organization Grade 3 Meningiomas.
Kim JT; Chang SJC; Haghdel A; Ramakrishna RR; Pannullo SC; Schwartz TH; Osborne JR; Magge RS; Fine HA; Cisse B; Stieg P; Lin E; Roytman M; Palmer JD; Karakatsanis NA; Pisapia D; Liechty B; Knisely JPS; Ivanidze J
AJNR Am J Neuroradiol; 2024 Jun; 45(6):773-780. PubMed ID: 38604734
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the Impact of 68Ga-DOTATATE and 18F-FDG PET/CT on Clinical Management in Patients with Neuroendocrine Tumors.
Panagiotidis E; Alshammari A; Michopoulou S; Skoura E; Naik K; Maragkoudakis E; Mohmaduvesh M; Al-Harbi M; Belda M; Caplin ME; Toumpanakis C; Bomanji J
J Nucl Med; 2017 Jan; 58(1):91-96. PubMed ID: 27516446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
